Literature DB >> 2988628

Glucocorticoid modulation of collagenase expression in human skin fibroblast cultures. Evidence for pre-translational inhibition.

E A Bauer, A Kronberger, K J Valle, J J Jeffrey, A Z Eisen.   

Abstract

Glucocorticoids inhibit collagenase accumulation in the medium of human skin explant cultures. To examine the mechanism for this process, skin fibroblasts were placed in serum-free medium containing various steroids. Dexamethasone produced a dose-dependent inhibition of trypsin-activatable collagenase in the culture medium with maximal inhibition of approx. 85% at 10(-6) M. Dexamethasone failed to inhibit collagenase activity directly. The decrease in activity in the medium was paralleled by a decrease in immunoreactive protein, suggesting inhibition of enzyme synthesis. The specificity of the effect was shown in two ways. At 10(-6) M steroid, only dexamethasone and hydrocortisone were inhibitory; estradiol, progesterone and testosterone produced less than 10% inhibition. In biosynthetic studies, exposure to 10(-7) M dexamethasone for 24 h produced approx. 50% inhibition of collagenase synthesis but caused no greater than 10% inhibition of total protein synthesis. The T1/2 for achieving the effect was approx. 16 h after initial exposure to dexamethasone. These kinetics were parallel to the inhibition caused by actinomycin D and cordycepin, two inhibitors of transcription, but were longer than that caused by cycloheximide (T 1/2 less than 3 h). To examine this process, cells were cultured in the presence or absence of 10(-6) M dexamethasone prior to harvesting mRNA for cell-free translation. In each case the inhibition or enzyme activity in the intact cells was paralleled by a reduction in translatable collagenase mRNA from the same cells. At the same time, there was no significant inhibition of total protein translation by the steroid. These data suggest that glucocorticoids regulate collagenase synthesis at a pre-translational level, possibly through inhibition of transcription.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2988628     DOI: 10.1016/0167-4781(85)90107-1

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  6 in total

1.  Regulation of the expression of tissue inhibitor of metalloproteinases and collagenase by retinoids and glucocorticoids in human fibroblasts.

Authors:  S D Clark; D K Kobayashi; H G Welgus
Journal:  J Clin Invest       Date:  1987-11       Impact factor: 14.808

2.  Differential regulation of glycosaminoglycan, fibronectin, and collagenase production in cultured human dermal fibroblasts by interferon-alpha, -beta, and -gamma.

Authors:  M R Duncan; B Berman
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

3.  Maintenance of embedded pig pancreatic pseudo-islets in a collagen gel matrix: study of the effect of hydrocortisone, a collagenase inhibitor, and nicotinamide on collagenolysis and the morphogenesis of pancreatic islet-cells in collagen gel matrix.

Authors:  H Ohgawara; N Mochizuki; T Taira; S Nishijima; N Iwasaki; R Yui; Y Hirata; T Hayakawa
Journal:  In Vitro Cell Dev Biol       Date:  1990-04

4.  11β-Hydroxysteroid dehydrogenase blockade prevents age-induced skin structure and function defects.

Authors:  Ana Tiganescu; Abd A Tahrani; Stuart A Morgan; Marcela Otranto; Alexis Desmoulière; Lianne Abrahams; Zaki Hassan-Smith; Elizabeth A Walker; Elizabeth H Rabbitt; Mark S Cooper; Kurt Amrein; Gareth G Lavery; Paul M Stewart
Journal:  J Clin Invest       Date:  2013-06-03       Impact factor: 14.808

5.  Influence of aging, localization, glucocorticoids and isotretinoin on matrix metalloproteases 2 (MMP-2) and 9 (MMP-9) in suction blister fluids.

Authors:  M Kylmäniemio; P Autio; A Oikarinen
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

6.  Calcipotriol counteracts betamethasone-induced decrease in extracellular matrix components related to skin atrophy.

Authors:  Hanne Norsgaard; Sandrine Kurdykowski; Pascal Descargues; Tatiana Gonzalez; Troels Marstrand; Georg Dünstl; Mads Røpke
Journal:  Arch Dermatol Res       Date:  2014-07-16       Impact factor: 3.017

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.